These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

836 related articles for article (PubMed ID: 10730528)

  • 41. Lupus nephritis in children--a review of 167 patients.
    Yang LY; Chen WP; Lin CY
    Pediatrics; 1994 Sep; 94(3):335-40. PubMed ID: 8065859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study.
    Zavada J; Pesickova S; Rysava R; Olejarova M; Horák P; Hrncír Z; Rychlík I; Havrda M; Vítova J; Lukác J; Rovensky J; Tegzova D; Böhmova J; Zadrazil J; Hána J; Dostál C; Tesar V
    Lupus; 2010 Oct; 19(11):1281-9. PubMed ID: 20605876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical predictors of recovery and complications in the management of recent-onset renal failure in lupus nephritis: a Chinese experience.
    Liang L; Yang X; Xu H; Zhan Z; Ye Y; Yu X; Chen W
    J Rheumatol; 2004 Apr; 31(4):701-6. PubMed ID: 15088294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crossroads of the effects of cyclophosphamide pulse therapy for lupus nephritis--experience of 11 cases.
    Funauchi M; Ikoma S; Sugiyama M; Yu H; Ohno M; Kinoshita K; Hamada K; Kanamaru A
    J Clin Lab Immunol; 1998; 50(2):45-54. PubMed ID: 10470622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens.
    Mok CC; Ho CT; Siu YP; Chan KW; Kwan TH; Lau CS; Wong RW; Au TC
    Am J Kidney Dis; 2001 Aug; 38(2):256-64. PubMed ID: 11479150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis.
    Yamaji K; Kim YJ; Tsuda H; Takasaki Y
    Ther Apher Dial; 2008 Aug; 12(4):298-305. PubMed ID: 18789117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous cyclophosphamide pulse therapy on children with severe active lupus nephritis.
    Yan DC; Chou CC; Tsai MJ; Chiang BL; Tsau YK; Hsieh KH
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(3):203-9. PubMed ID: 7618472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A case of lupus nephritis resistant to steroid pulse therapy markedly improved by bolus intravenous cyclophosphamide therapy].
    Moriuchi J; Ichikawa Y; Takaya M; Shimizu H; Kurata T; Arimori S
    Ryumachi; 1989 Aug; 29(4):291-6. PubMed ID: 2617371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose.
    Tanaka H; Oki E; Tsuruga K; Yashiro T; Hanada I; Ito E
    Clin Nephrol; 2009 Dec; 72(6):430-6. PubMed ID: 19954719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment and renal outcome of lupus nephritis: single center experience.
    Go KW; Teo SM
    Med J Malaysia; 2006 Oct; 61(4):447-50. PubMed ID: 17243522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Appraisal of renal failure reversing therapies in lupus nephritis].
    Yang X; Liang L; Zhan Z; Ye Y; Liu Y; Yu X; Chen W; Yin P
    Zhonghua Nei Ke Za Zhi; 2001 Feb; 40(2):113-6. PubMed ID: 11798566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved survival in lupus nephritis in the modern era (1979 - 1989).
    Mc'Ligeyo SO; Cameron SJ; Williams GD; Ogg C; Hartley RB; Chantler C; Haycock GB; Sacks S; Rigden R; Hicks JA
    Afr J Health Sci; 1995 Feb; 2(1):211-219. PubMed ID: 12160446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
    Gunnarsson I; Sundelin B; Jónsdóttir T; Jacobson SH; Henriksson EW; van Vollenhoven RF
    Arthritis Rheum; 2007 Apr; 56(4):1263-72. PubMed ID: 17393458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis.
    Lee T; Oh KH; Joo KW; Kim YS; Ahn C; Han JS; Kim S; Chin HJ
    Lupus; 2010 Jul; 19(8):974-80. PubMed ID: 20581020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis.
    Takada K; Arefayene M; Desta Z; Yarboro CH; Boumpas DT; Balow JE; Flockhart DA; Illei GG
    Arthritis Rheum; 2004 Jul; 50(7):2202-10. PubMed ID: 15248218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW; Fluck RJ; Lambie SH
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Response to treatment as a predictor of longterm outcome in patients with lupus nephritis.
    Fraenkel L; MacKenzie T; Joseph L; Kashgarian M; Hayslett JP; Esdaile JM
    J Rheumatol; 1994 Nov; 21(11):2052-7. PubMed ID: 7869309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renal outcome in patients with lupus nephritis using a steroid-free regimen of monthly intravenous cyclophosphamide: a prospective observational study.
    Fischer-Betz R; Chehab G; Sander O; Vordenbäumen S; Voiculescu A; Brinks R; Schneider M
    J Rheumatol; 2012 Nov; 39(11):2111-7. PubMed ID: 22984276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cyclophosphamide bolus therapy in lupus nephritis].
    Witte T; Schaumann D; Hein R; Helmchen U; Neumann KH; Koch KM; Deicher H; Schmidt RE
    Dtsch Med Wochenschr; 1993 Jul; 118(27-28):1005-10. PubMed ID: 8334946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intermittent intravenous treatment of lupus nephritis with cyclophosphamide: a four-year experience with twenty-four patients.
    Chu SJ; Chang DM; Kuo SY; Hsu CM; Chen CM; Chang ML
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jun; 53(6):325-30. PubMed ID: 8087706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.